SSX5 (NM_021015) Human Mass Spec Standard
Specifications
| Product Data | |
| Tag | C-Myc/DDK |
|---|---|
| Species | Human |
| Expression Host | HEK293 |
| Expression cDNA Clone or AA Sequence | RC202208 |
| Predicted MW | 26.3 kDa |
| Protein Sequence | |
| Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
| Concentration | >0.05 µg/µL as determined by microplate BCA method |
| Labeling Method | Labeled with U- 13C6, 15N4-L-Arginine and U- 13C6, 15N2-L-Lysine |
| Buffer | 25 mM Tris-HCl, 100 mM glycine, pH 7.3 |
| Storage | Store at -80°C. Avoid repeated freeze-thaw cycles. |
| Stability | Stable for 3 months from receipt of products under proper storage and handling conditions. |
| Shipping | Dry Ice |
| Reference Data | |
| RefSeq | NP_066295 |
| RefSeq Size | 1399 |
| RefSeq ORF | 687 |
| Locus ID | 6758 |
| UniProt ID | O60225 |
| Cytogenetics | Xp11.23 |
| Summary | The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneous humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. While some of the related SSX genes are involved in t(X;18)(p11.2;q11.2) translocations that are characteristically found in all synovial sarcomas, this gene does not appear to be involved in such translocations. Two transcript variants encoding distinct isoforms have been identified for this gene. provided by RefSeq, Jul 2013 |
| Protein Families | Transcription Factors |
Reviews
Documents
| FAQs |
| SDS |
Resources
| Recombinant Protein Resources |
Other "SSX5" proteins (5)
| SKU | Description | Size | Price | |
|---|---|---|---|---|
| LC406264 | Lyophilized SSX5 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
| LC412141 | Lyophilized SSX5 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
| LY406264 | Transient overexpression lysate of synovial sarcoma, X breakpoint 5 (SSX5), transcript variant 2 (as WB positive control) | 100 ug |
$436.00
|
|
| LY412141 | Transient overexpression lysate of synovial sarcoma, X breakpoint 5 (SSX5), transcript variant 1 (as WB positive control) | 100 ug |
$436.00
|
|
| TP302208 | Recombinant protein of human synovial sarcoma, X breakpoint 5 (SSX5), transcript variant 1, 20 µg | 20 ug |
$867.00
|
|
Citations
Related Products
- Price:
- Actual Price:
Welcome to OriGene AI!
I'm your AI-powered guide to everything OriGene.
Ask me anything:
- Product specs
- Ordering help
- Technical questions
- How to find exactly what your experiment needs
Prefer a live agent? Connect with us by clicking the green chat icon, as seen in the image below or email our team at custsupport@origene.com.